Discrepancies in Xpert tuberculosis testing
Main Authors: | Ebrahim Variava, Tumelo Moloantoa, Neil A Martinson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | The Lancet Microbe |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666524720300331 |
Similar Items
-
Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp Hospital
by: Relebohile Ncha, et al.
Published: (2019-08-01) -
The Use of Xpert MTB/Rif for Active Case Finding among TB Contacts in North West Province, South Africa
by: Limakatso Lebina, et al.
Published: (2016-01-01) -
The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis
by: Arista Nienaber, et al.
Published: (2021-03-01) -
Pyrosequencing to resolve discrepant Xpert MTB/RIF and Mycobacterial Growth Indicator Tube 960
by: Kanchan Ajbani, et al.
Published: (2018-01-01) -
The Feasibility of Screening Test for Mycobacterium Tuberculosis Using Xpert MTB/RIF
by: YU, FANG-LAN, et al.
Published: (2018)